UBS Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,200
| Closed | -$1K | – | 7465 |
|
|
2019
Q1 | $1K | Hold |
1,200
| – | – | ﹤0.01% | 6819 |
|
|
2018
Q4 | $1K | Hold |
1,200
| – | – | ﹤0.01% | 7040 |
|
|
2018
Q3 | $3K | Sell |
1,200
-1,164
| -49% | -$2.91K | ﹤0.01% | 6778 |
|
|
2018
Q2 | $6K | Buy |
2,364
+1,164
| +97% | +$2.95K | ﹤0.01% | 6519 |
|
|
2018
Q1 | $4K | Sell |
1,200
-5,237
| -81% | -$17.5K | ﹤0.01% | 6496 |
|
|
2017
Q4 | $27K | Buy |
6,437
+1,026
| +19% | +$4.3K | ﹤0.01% | 5382 |
|
|
2017
Q3 | $25K | Buy |
5,411
+1,745
| +48% | +$8.06K | ﹤0.01% | 5415 |
|
|
2017
Q2 | $12K | Sell |
3,666
-321
| -8% | -$1.05K | ﹤0.01% | 5747 |
|
|
2017
Q1 | $37K | Sell |
3,987
-4,326
| -52% | -$40.1K | ﹤0.01% | 4837 |
|
|
2016
Q4 | $65K | Sell |
8,313
-457
| -5% | -$3.57K | ﹤0.01% | 4726 |
|
|
2016
Q3 | $100K | Buy |
8,770
+4,486
| +105% | +$51.2K | ﹤0.01% | 4149 |
|
|
2016
Q2 | $53K | Sell |
4,284
-2,059
| -32% | -$25.5K | ﹤0.01% | 4633 |
|
|
2016
Q1 | $64K | Sell |
6,343
-6,038
| -49% | -$60.9K | ﹤0.01% | 4528 |
|
|
2015
Q4 | $279K | Buy |
12,381
+8,272
| +201% | +$186K | ﹤0.01% | 3555 |
|
|
2015
Q3 | $68K | Sell |
4,109
-1,308
| -24% | -$21.6K | ﹤0.01% | 4472 |
|
|
2015
Q2 | $122K | Buy |
5,417
+1,008
| +23% | +$22.7K | ﹤0.01% | 4168 |
|
|
2015
Q1 | $114K | Buy |
4,409
+986
| +29% | +$25.5K | ﹤0.01% | 4112 |
|
|
2014
Q4 | $75K | Buy |
+3,423
| New | +$75K | ﹤0.01% | 4425 |
|